The Company has granted the underwriters a 30-day option to purchase up to 3,075,000 additional shares of common stock. The Company estimates that the net proceeds from the Offering after underwriting discounts and commissions and estimated offering expenses, will be approximately $189,880,000 or approximately $218,662,000 if the underwriters' option to purchase additional shares is exercised in full.
BofA Merrill Lynch, J.P. Morgan, Deutsche Bank Securities, KeyBanc Capital Markets and RBC Capital Markets are acting as joint bookrunning managers for the Offering; SunTrust Robinson Humphrey as lead manager; and Morgan Keegan, Raymond James, JMP Securities and Stifel Nicolaus Weisel as co-managers.
The Company intends to use the net proceeds from the Offering to fund a portion of the consideration for the acquisition of assets from and loans to Ernest Health, Inc. (the "Ernest Acquisition Transactions"), which were announced yesterday, January 31, 2012. The Offering is not conditioned on the completion of the transactions with Ernest Health, Inc.
The Offering is expected to close on February 7, 2012, subject to customary closing conditions. All of the shares of common stock will be issued by the Company and will be issued under the Company's currently effective shelf registration statement on Form S-3 filed with the Securities and Exchange Commission ("SEC"). For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment